Events
|
30 August 2026
ISLB Annual Congress 2026 | 7-9 November | Madrid, Spain
Actorius will present seven scientific posters at ISLB 2026 in Madrid, showcasing research advancing the clinical potential of CTCs across treatment monitoring, biomarker analysis, residual disease, and metastasis research.
Seven studies. One shared goal: advancing the clinical potential of circulating tumor cells.
This November, at ISLB 2026 in Madrid, Actorius will present seven scientific posters at the International Society of Liquid Biopsy Congress—the highest number of accepted posters from any academic group or company.
Our team will be presenting research spanning CTC biology, treatment monitoring, biomarker expression, algorithm-based analysis, minimal cellular residual disease, and extracorporeal approaches.
Our Poster Presentations
Across these seven studies, one theme connects our work:
That is making circulating tumor cells more clinically meaningful—from understanding tumor biology and treatment response to monitoring residual disease and exploring new approaches to metastasis.
Meet our Founders
Our three co-founders will also be at ISLB Annual congress. If you work in liquid biopsy, CTC biology, oncology research, or precision oncology, we would be glad to connect and exchange perspectives.
Visit us at Booth 7
Meet us in Madrid, or book a meeting in advance
#ISLB2026 #LiquidBiopsy #CirculatingTumorCells #CTC #PrecisionOncology #CancerResearch #OncologyResearch #Actorius #CancerDiagnostics #Metastasis Research
Stay One Step
Ahead of Cancer.
Get the latest news and innovations from Actorius delivered straight to your inbox.

